Molecular Pharmacology (USA) LtdOTC Pink - Limited Information:MLPH
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Molecular Pharmacology (USA) Ltd | 100.0K | -0.1x | --- |
Innovation Pharmaceuticals Inc | 103.7K | 0.0x | --- |
GB Sciences Inc | 40.7K | 0.0x | --- |
Life Stem Genetics Inc | 24.6K | 0.0x | --- |
Vioquest Pharmaceuticals Inc | 43.1K | 0.0x | --- |
Vaxxinity Inc | 25.4K | 0.0x | --- |
Company Information
Molecular Pharmacology (USA) Limited (Molecular USA) is an Australia-based development Stage company together with its subsidiary, Molecular Pharmacology Pty. Ltd. (MPLA) is in the business of developing and commercializing an analgesic and anti-inflammatory molecule known as Tripeptofen. The Company’s over-the-counter anti-pain and anti-inflammatory products sold for the treatment of acute localized pain are based on non-steroidal anti-inflammatory drugs (NSAIDs). The licensed products include all products in all dosage forms, formulations, line extensions and package configurations using production method of metallo-polypeptide analgesic and anti-inflammatory activity as an active ingredient marketed by MPLA or its affiliates under the trade name Tripeptofen. The Company and Molecular Pharmacology Pty. Ltd. have no manufacturing facilities.
Contact Information
- Headquarters
- Drug Discovery Research Ctr 284 Oxford StLEEDERVILLE, WAS, Australia 6007
- Phone
- ---
- Fax
- ---
Executives
- President, Chief Executive Officer, Chief Financial Officer, Director
- Jeffery Edwards
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $100.0K |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 999.6M |
Molecular Pharmacology (USA) Ltd does not pay a dividend. | |
Beta | --- |
EPS | $0.00 |
Book Value | $-0.02 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
